Published • loading... • Updated
Cost and Testing Access Limit Biomarker-Guided Breast Cancer Care in
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
BIOENGINEER.ORGReposted by 
Scienmag: Latest Science and Health News
Scienmag: Latest Science and Health NewsCost and Testing Access Limit Biomarker-Guided Breast Cancer Care in
A survey of 27 medical oncologists in Benghazi found that most rate biomarker testing as extremely important for breast cancer treatment decisions, but high cost and limited testing centres are the leading reported barriers.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
